Ever since High Frequency Chest Wall Oscillation (HFCWO) devices were developed to help patients with cystic fibrosis breathe easier, clinical researchers…
Articles by Maureen Newman
Anthera Pharmaceuticals, Inc. is initiating a Phase 3 clinical trial entitled SOLUTION (Study of Oral Liprotamase…
Researchers at Institut national de la santé et de la recherche médicale (INSERM) in France have learned one way…
In both adolescents and adults, nutritional status can play a major role in the rate of disease progression. Individuals with…
Treating the root cause of cystic fibrosis, rather than just the symptoms, may be an ideal approach to improving patient outcomes…
The pathogen Pseudomonas aeruginosa is the most common infectious agent that affects cystic fibrosis patients and leads to chronic pulmonary…
Newly found workings of Pseudomonas aeruginosa may explain why certain medications are only modestly effective in patients with cystic fibrosis.
Gene therapy in the context of treating cystic fibrosis made a significant step forward with the announcement of positive data…
Accuracy and efficiency are of utmost importance when deciding on a diagnostic tool to detect cystic fibrosis in newborns. The…
Coughing, wheezing, breathlessness during exercise, and increased sputum production are typical cystic fibrosis symptoms. However, these are also the symptoms of…